Article
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jun 2011
Ciurea Stefan O, Saliba Rima M, Rondon Gabriela, Patah Poliana A, Aung Fleur, Cano Pedro, Andersson Borje S, Kebriaei Partow, Popat Uday, Fernandez-Vina Marcelo, Champlin Richard E, de Lima Marcos
Abstract excerpt
Most candidates for hematopoietic stem cell transplantation (HSCT) lack a human leukocyte antigen (HLA)-identical sibling donor. Some patients may have a related donor with whom they are mismatched at 1 antigen/allele. It is not known whether such a match is preferable to a matched unrelated donor (MUD). We evaluated the outcomes (survival, relapse, nonrelapse mortality [NRM]) of all 28 patients with a single HLA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
